Form CORRESP - Correspondence:
SEC Accession No. 0001193125-12-221874
Filing Date
2012-05-09
Accepted
2012-05-09 15:41:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 7165
  Complete submission text file 0001193125-12-221874.txt   8023
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations